Cirrhotic ascites & SBP
Decompensated cirrhosis · Gastroenterology
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
New or worsening ascites in cirrhosis. Confirm a portal-hypertensive cause with the SAAG (≥1.1 g/dL) and always exclude spontaneous bacterial peritonitis (SBP) with a diagnostic tap on every admission.
Assessment
Differential diagnosis
- Cardiac ascites (heart failure / constrictive pericarditis)
- Budd–Chiari syndrome
- Peritoneal TB
- Peritoneal carcinomatosis
- Nephrotic syndrome
- Pancreatic ascites
Investigations
- Diagnostic paracentesis: cell count & differential, albumin (for SAAG), total protein, culture into blood-culture bottles at the bedside
- Paired serum albumin the same day → SAAG = serum albumin − ascitic albumin
- FBC, U&E, LFTs, coagulation; ascitic PMN ≥250/mm³ = SBP (treat even if culture negative)
Management
- Diagnostic tap on every admission with ascites — do not defer
- Calculate SAAG; ≥1.1 g/dL confirms portal hypertension
- Salt restriction + spironolactone (± furosemide, 100:40 ratio)
- Tense ascites → large-volume paracentesis with albumin 6–8 g per litre removed
- PMN ≥250/mm³ → IV cefotaxime + IV albumin (1.5 g/kg day 1, 1 g/kg day 3)
- Refractory ascites → repeated LVP, TIPS referral, transplant assessment
Disposition
Admit decompensated cirrhosis and any SBP. Hepatology referral; transplant assessment for refractory disease.
Exam pearls
- Every cirrhotic admitted with ascites needs a diagnostic tap — SBP is often silent
- SAAG ≥1.1 g/dL = portal hypertension (transudate); <1.1 = non-portal cause
- Give albumin with large-volume paracentesis and in SBP — it improves survival
- Avoid NSAIDs, aminoglycosides and other nephrotoxins; beware hepatorenal syndrome
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.